NBE-Therapeutics raised €19M in a Series C round in Oct 2020. The company is based in Basel, Switzerland. Investors in the round: Boehringer Ingelheim, PPF Group. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
